hotspot -WSS

hotspot

author：explore 2025-09-29 21:14:01 - browse：6161

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： In science, is the line between industry and academia shifting?

hotspot

WSS

How Long Island became the ‘eugenics capital of the world’

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Wegovy cuts risk of cardiovascular events by 20%, study finds

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Astronauts get first look at the spacecraft that will fly them around the moon

hotspot

hotspot

Wikipedia

The cancer drug shortage isn’t new — and neither are the solutions

What AAP's gender

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Ohioans vote in high

After affirmative action ruling, medical educators look to 'holistic review'

CDC advisory panel says seniors 'may' get RSV vaccine

Medical records are filled with copy

What do new weight loss drugs mean for bariatric surgery?

At least 13 dead in Texas as scorching temps continue

How to make Best Hospitals ratings actually useful for patients

entertainment

Wegovy cuts risk of cardiovascular events by 20%, study finds

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Medicare explains how it will choose drugs for negotiation

CDC advisory panel says seniors 'may' get RSV vaccine

Lessons Learned: This is why you network to find that industry job you want

Neuroscience startup Neumora files for IPO

knowledge

hotspot

focus

focus